IMVT Immunovant, Inc.
$37.36▼ -1.94%
Healthcare
Other
After hours
$36.83▼ -1.42%
Sep 11, 7:30 PM ET
Volume 1.03M
Avg Volume (10D) 1.19M
Key Metrics & Fundamentals
Market Cap
$7.72B
P/E Ratio
–
Div Yield
–%
52W Range
14.58 - 45.42
% vs 50 MA
-7.61%
% vs 200 MA
21.03%
RSI-14
31.8
MACD Histogram
-0.6500
Beta (1Y vs SPY)
1.36
Free Cash Flow
-$124.41M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$160.23M
COGS
–
Operating Exp
$160.32M
Operating Income
-$160.32M
EBIT
-$160.32M
Pretax Income
-$153.22M
Net Income
-$153.22M
EPS (Diluted)
-0.75
Price & Volume History
Loading chart…
Recent News
Rosnilimab Emerges as a Potential Advance in Rheumatoid Arthritis as Physicians Look to the Next Wave of Pipeline Innovation
GlobeNewswire · Sep 10, 2026 12:52 PM
Immunovant's Risk/Reward Profile Balanced After Recent Rally, UBS Says
MT Newswires · Aug 24, 2026 5:16 PM
UBS Adjusts Immunovant Price Target to $40 From $24, Maintains Neutral Rating
MT Newswires · Aug 24, 2026 2:09 PM
Immunovant (IMVT) Q1 2027 Earnings Call Transcript
Motley Fool · Aug 13, 2026 12:01 PM
Roivant Sciences Q1 Earnings Call Highlights
MarketBeat · Aug 7, 2026 11:03 AM
Immunovant, Inc. Q1 2027 Earnings Call Summary
Moby · Aug 6, 2026 9:51 PM
Immunovant Q1 Earnings Call Highlights
MarketBeat · Aug 6, 2026 7:04 PM
Immunovant's Q1 Loss Wider Than Expected, Pipeline in Progress
Zacks · Aug 6, 2026 3:22 PM
Immunovant Fiscal Q1 Loss Widens
MT Newswires · Aug 6, 2026 12:35 PM
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
GlobeNewswire · Aug 6, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IMVT's money flow as a full page
Social Sentiment
Avg +0.05 · 2 posts
list of all pre-revenue companies sorted by market capitalization.
r/stocks · Sep 24, 2025
The comments highlight the speculative nature of the stocks listed, particularly OKLO, suggesting overvaluation and a lack of concrete product or revenue.
negative
-0.60
TradeDiscussionBiotech trading or investing is hard, but what if you follow the smart money?
r/wallstreetbets · Oct 8, 2024
IMVT is identified as a top pick based on hedge fund activity, indicating a positive outlook.
positive
+0.70
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.